Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



JOHNSON JOHN Create: Alert

All | News | Filings
Date FiledTypeDescription
06/07/2023 4 JOHNSON JOHN (Director) has filed a Form 4 on Xeris Biopharma Holdings, Inc.
Txns: Granted 42,500 shares @ $0
06/05/2023 4 JOHNSON JOHN (Director) has filed a Form 4 on Axogen, Inc.
Txns: Exercised 6,459 restricted stock units @ $0
05/16/2023 4 JOHNSON JOHN (Director) has filed a Form 4 on Verastem, Inc.
Txns: Granted 62,500 options to buy @ $0.42, valued at $26.3k
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/06/2021 4 JOHNSON JOHN (CEO) has filed a Form 4 on Strongbridge Biopharma plc
Txns: Disposed/sold 610,092 shares @ $0
Disposed/sold 495,724 options to buy @ $0
10/05/2021 4 JOHNSON JOHN (Director) has filed a Form 4 on Xeris Biopharma Holdings, Inc.
Txns: Granted 478,312 shares @ $0
Granted 10,367 options to buy @ $22.39, valued at $232.1k
Granted 31,360 options to buy @ $7.02, valued at $220.1k
Granted 31,360 options to buy @ $5.62, valued at $176.2k
Granted 31,360 options to buy @ $9.89, valued at $310.2k
Granted 215,600 options to buy @ $1.99, valued at $429k
Granted 68,600 options to buy @ $2.43, valued at $166.7k
10/05/2021 4 JOHNSON JOHN (CEO) has filed a Form 4 on Strongbridge Biopharma plc
Txns: Paid exercise price by delivering 334,868 shares @ $2.06, valued at $689.8k
07/21/2021 4 JOHNSON JOHN (Director) has filed a Form 4 on Axogen, Inc.
Txns: Granted 27,638 options to buy @ $19.44, valued at $537.3k
07/07/2021 4 JOHNSON JOHN (CEO) has filed a Form 4 on Strongbridge Biopharma plc
Txns: Paid exercise price by delivering 50,867 shares @ $3.08, valued at $156.7k
06/30/2021 4 JOHNSON JOHN (Director) has filed a Form 4 on Verastem, Inc.
Txns: Granted 25,000 options to buy @ $4.16, valued at $104k
04/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/08/2021 4 JOHNSON JOHN (CEO) has filed a Form 4 on Strongbridge Biopharma plc
Txns: Granted 491,000 shares @ $0
07/07/2020 4 JOHNSON JOHN (CEO) has filed a Form 4 on Strongbridge Biopharma plc
Txns: Granted 315,000 shares @ $0
07/02/2020 4 JOHNSON JOHN (Director) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Disposed/sold 13,194 shares @ $18, valued at $237.5k
Disposed/sold 7,281 restricted stock units @ $18, valued at $131.1k
Disposed/sold 11,377 options to buy @ $17.94, valued at $204.1k
Disposed/sold 54,991 options to buy @ $0
06/18/2020 4 JOHNSON JOHN (Director) has filed a Form 4 on Verastem, Inc.
Txns: Granted 27,602 options to buy @ $1.77, valued at $48.9k
06/15/2020 4 JOHNSON JOHN (Director) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Granted 7,281 shares @ $0
Granted 11,377 options to buy @ $17.94, valued at $204.1k
05/18/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/29/2020 4 JOHNSON JOHN (Director) has filed a Form 4 on Verastem, Inc.
Txns: Granted 25,000 options to buy @ $1.81, valued at $45.3k
04/10/2020 4 JOHNSON JOHN (Executive Chairman) has filed a Form 4 on Strongbridge Biopharma plc
Txns: Granted 182,500 shares @ $0
Granted 87,500 options to buy @ $1.9, valued at $166.3k
11/18/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/02/2019 4 JOHNSON JOHN (CEO) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/
Txns: Sold 13,000 shares @ $5.5724, valued at $72.4k
06/26/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2019 4 JOHNSON JOHN (Director) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Granted 4,194 shares @ $0
Granted 6,991 options to buy @ $26.09, valued at $182.4k
05/16/2019 4 JOHNSON JOHN (Director) has filed a Form 4 on Strongbridge Biopharma plc
Txns: Granted 40,000 shares @ $0
02/26/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/29/2018 4 JOHNSON JOHN (Interim CEO) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/
Txns: Granted 150,000 options to buy @ $2.8, valued at $420k
Granted 50,000 restricted stock units @ $0
06/19/2018 4 JOHNSON JOHN (Director) has filed a Form 4 on HISTOGENICS CORP
Txns: Granted 25,000 options to buy @ $2.97, valued at $74.3k
06/14/2018 4 JOHNSON JOHN (Director) has filed a Form 4 on MELINTA THERAPEUTICS, INC. /NEW/
Txns: Granted 25,000 options to buy @ $7.45, valued at $186.3k
Granted 9,100 options to buy @ $7.45, valued at $67.8k
06/08/2018 4 JOHNSON JOHN (Director) has filed a Form 4 on PORTOLA PHARMACEUTICALS INC
Txns: Granted 3,000 shares @ $0
Granted 6,000 options to buy @ $42.81, valued at $256.9k
05/17/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/13/2018 4 JOHNSON JOHN (Director) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.
Txns: Disposed/sold 5,130 shares @ $18, valued at $92.3k
Disposed/sold 30,000 options to buy @ $13.92, valued at $417.6k
Disposed/sold 20,000 options to buy @ $16.23, valued at $324.6k
Disposed/sold 10,000 options to buy @ $10.3, valued at $103k
02/05/2018 4 JOHNSON JOHN (Director) has filed a Form 4 on AVEO PHARMACEUTICALS INC
Txns: Granted 100,000 options to buy @ $3.08, valued at $308k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy